Nebraska Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Nebraska Collateral License Agreement, often referred to as the Nebraska CLA, is a legal contract between Gentling, Inc. and The University of North Texas Health Science Center (UNT HSC). This agreement outlines the terms and conditions regarding the intellectual property rights and commercialization of certain technologies or inventions developed as a result of collaborative efforts between the parties involved. This agreement is designed to ensure that any advancements or innovations made by Gentling, Inc. or UNT HSC are appropriately protected and utilized for both research and commercial purposes. The Nebraska Collateral License Agreement grants Gentling, Inc. the exclusive rights to utilize, market, and sell any products or services based on the licensed technologies, while providing UNT HSC with certain financial considerations and royalties. There may be different types of Nebraska Collateral License Agreement between Gentling, Inc. and UNT HSC, depending on the specific technologies or inventions being licensed. These license agreements can vary in scope, duration, and exclusivity. They are tailored to address the unique aspects of each technology and the desires of both parties involved. In some cases, Nebraska Collateral License Agreements may be exclusive, meaning that Gentling, Inc. has the sole rights to exploit the licensed technologies within a specific field or market. Other agreements may be non-exclusive, allowing UNT HSC to grant licenses to other entities or organizations as well. Furthermore, the duration of the licensing agreement may vary, depending on factors such as the advancement of the technology, market conditions, and the parties' mutual agreement. By entering into a Nebraska Collateral License Agreement, Gentling, Inc. gains access to valuable intellectual property rights developed by UNT HSC, enabling them to leverage these innovations for the furtherance of their business goals. At the same time, UNT HSC benefits from the agreement by receiving financial considerations, royalties, and potential collaborations for further research and development. Overall, the Nebraska Collateral License Agreement represents a mutually beneficial collaboration between Gentling, Inc. and UNT HSC, allowing for the advancement and commercialization of cutting-edge technologies and inventions that can have a significant impact on various industries and improve the lives of individuals.

Nebraska Collateral License Agreement, often referred to as the Nebraska CLA, is a legal contract between Gentling, Inc. and The University of North Texas Health Science Center (UNT HSC). This agreement outlines the terms and conditions regarding the intellectual property rights and commercialization of certain technologies or inventions developed as a result of collaborative efforts between the parties involved. This agreement is designed to ensure that any advancements or innovations made by Gentling, Inc. or UNT HSC are appropriately protected and utilized for both research and commercial purposes. The Nebraska Collateral License Agreement grants Gentling, Inc. the exclusive rights to utilize, market, and sell any products or services based on the licensed technologies, while providing UNT HSC with certain financial considerations and royalties. There may be different types of Nebraska Collateral License Agreement between Gentling, Inc. and UNT HSC, depending on the specific technologies or inventions being licensed. These license agreements can vary in scope, duration, and exclusivity. They are tailored to address the unique aspects of each technology and the desires of both parties involved. In some cases, Nebraska Collateral License Agreements may be exclusive, meaning that Gentling, Inc. has the sole rights to exploit the licensed technologies within a specific field or market. Other agreements may be non-exclusive, allowing UNT HSC to grant licenses to other entities or organizations as well. Furthermore, the duration of the licensing agreement may vary, depending on factors such as the advancement of the technology, market conditions, and the parties' mutual agreement. By entering into a Nebraska Collateral License Agreement, Gentling, Inc. gains access to valuable intellectual property rights developed by UNT HSC, enabling them to leverage these innovations for the furtherance of their business goals. At the same time, UNT HSC benefits from the agreement by receiving financial considerations, royalties, and potential collaborations for further research and development. Overall, the Nebraska Collateral License Agreement represents a mutually beneficial collaboration between Gentling, Inc. and UNT HSC, allowing for the advancement and commercialization of cutting-edge technologies and inventions that can have a significant impact on various industries and improve the lives of individuals.